Teva launches ADHD drug

NORTH WALES, Pa. — Teva Pharmaceuticals has introduced a generic drug for treating attention deficit hyperactivity disorder, the company said.

Teva announced the launch of methylphenidate hydrochloride extended-release capsules in the 20-mg, 30-mg and 40-mg strength. The drug, a generic version of Novartis' Ritalin, is available in 100-pill bottles.

"Generic pharmaceuticals are playing an increasingly important role in healthcare cost containment," Teva SVP U.S. generics sales and marketing Maureen Cavanaugh said. "Teva Pharmaceuticals continues to lead the way with timely new product launches."

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.